KCM
PFE icon

Key Capital Management’s Pfizer PFE Stock Holding History

Key Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.2K Sell
2,832
-936
-25% -$24.5K 0.04% 141
2026
Q1 		$106K Buy
3,768
+1,038
+38% +$27.6K 0.07% 95
2025
Q4 		$68K Buy
+2,730
New +$68.8K 0.07% 113

Other funds holding PFE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Key Capital Management's PFE Position: Q2 2026 in Review

Key Capital Management reduced its Pfizer (PFE) stake by 25% in Q2 2026, selling an estimated $24.5K and leaving 2,832 shares worth $68.2K. The position accounts for 0.04% of the portfolio, ranked #141.

Key Capital Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $106K in Q1 2026. 1,694 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Key Capital Management held 2,832 shares of Pfizer worth $68.2K as of Q2 2026.
  • Key Capital Management sold 936 Pfizer shares in Q2 2026, an estimated $24.5K.
  • Pfizer made up 0.04% of Key Capital Management's portfolio in Q2 2026, its #141 holding.
  • Key Capital Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Key Capital Management's Pfizer position peaked at $106K in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.